Navigation Links
FDA Warns Against Birth-Control Patch

Users of the popular Ortho Evra birth control patch are being exposed to more hormones, and at higher risk of blood clots and other serious side effects than previously disclosed, //the United States Food and Drug Administration has warned.

According to a report by the Associated Press, regulators and patch-maker Ortho McNeil, a Johnson and Johnson subsidiary, had so far maintained that the patch would have similar risks as the pill. But the warning said the women using the patch would be exposed to about 60 percent more estrogen than those using typical birth control pills. When women take the pill, the medication is absorbed into the bloodstream through the digestive tract. In the process, about half of the estrogen dose is lost.

Although most pills and the patch are loaded with the same amount of estrogen, hormones from patches go directly into the bloodstream while pills are swallowed and digested first. The result is that women using the patch have much higher levels of estrogen in their bodies.

Four months ago, the AP had reported that patch users die and suffer blood clots at a rate three times higher than women taking the pill. Citing federal death and injury reports, the news agency also found that about a dozen women, most in their late teens and early 20s, died in 2004 from blood clots believed to be related to the birth-control patch, and dozens more survived strokes and other clot-related problems.

More than 4 million women have used the patch since it went on sale in 2002. Several lawsuits have been filed by families of women who died or suffered blood clots while using the patch, and lawyers said more are planned.

Documents released to attorneys show that Ortho McNeil has been analyzing the FDA's death and injury reports, creating its own charts that document a higher rate of blood clots and deaths in association with the patch than with the pill.

Hormone levels in women on the pill ar e highest one or two hours after taking it. Twelve hours later, estrogen levels are quite low, meaning the body is not exposed to high levels of estrogen 24 hours a day, said Dr. Leslie Miller, an associate professor of obstetrics and gynecology at the University of Washington.

But the patch causes higher estrogen levels since delivery of medication continues all day. Those elevated levels may be high enough to increase some women's risk of blood clots, Miller said. "If the patch is delivering too much estrogen, then it may need to be redesigned," Miller said.

Even before the warning, some advocacy groups and medical providers were raising questions about the patch.

In September, Public Citizen's Health Research Group, a consumer advocacy organization, added Ortho Evra to its ongoing list of dangerous medicines, warning that there is "no medical reason for women to use the more dangerous Ortho Evra rather than one of the older, better understood, and equally effective oral contraceptives."

And last month, Dr. Miguel Cano, an obstetrician and gynecologist in Reedley, Calif., sent a note to several thousand women patients recommending that they stop using the patch and that they come in for appointments to get a new form of birth control.
'"/>




Related medicine news :

1. Paracetamol May Cause Live Damage Warns Consumer Education and Research Centre
2. Study Warns About The Use Of Popular Asthma Drug To Stop Childrens Coughs
3. ADB Report Warns of Bird-Flu Catastrophe
4. Charlotte Church Warns kiss n tell girls not to flirt with Henson
5. UK Committee Warns on Food Shortages Due to Flu Epidemic
6. NHS Audit Commission Warns Possible Financial Collapse In Sussex And Surrey
7. Bishop Warns Against Change in Mercy Killing Laws
8. Manitoba Ombudsman Warns Pharmacists
9. FDA Warns VaxGen On Anthrax Vaccine
10. Doctors In New Zealand Warns Against Using Ayurveda Medicines
11. Oxford Radcliffe Hospitals Warns Of Further Job Losses
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/23/2017)... ... 23, 2017 , ... Drs. Allen Huang and Jeffrey Wang, ... Las Vegas, NV, and the importance of treating it immediately. They are now ... for peri-implantitis, with or without a referral. As experienced periodontists and implant specialists, ...
(Date:5/23/2017)... ... May 23, 2017 , ... Diagnotes, an Indianapolis-based digital ... feature on its secure clinical communication platform. The platform allows clinicians to easily ... the type and urgency of a situation. , “We know from our ...
(Date:5/23/2017)... ... May 23, 2017 , ... Orbita’s Nathan Treloar will discuss the role of ... Francisco. Titled Connected Health and IoT: Technology Innovators and Disruption , the workshop ... Associates, a market research and consulting firm specializing in emerging consumer technology products and ...
(Date:5/23/2017)... ... 23, 2017 , ... New patients looking for an alternative ... or without a referral, from the multi-specialty Dr. Smile practice. Dr. Esther Feldman ... in providing patients with the custom, convenient and long-lasting orthodontic treatment that helps ...
(Date:5/23/2017)... Mt. Horeb, WI (PRWEB) , ... May 23, 2017 , ... ... now invited to call Dr. Angela Cotey’s practice to schedule an appointment, with or ... dentistry services, and frequently offers pulpotomy treatments to pediatric patients as a healthy alternative ...
Breaking Medicine News(10 mins):
(Date:5/4/2017)... Fix Inc. (" Fortuna "), a private, clinical-stage biotech ... need for embryonic and fetal stem cells by using direct ... Fortuna announced today the launch of its Scientific ... PhD; Father Kevin FitzGerald , S.J., PhD; Col. (R) ... Giordano , PhD. "We are excited and honored ...
(Date:5/4/2017)... , May 4, 2017  DarioHealth Corp. (NASDAQ: ... health and big data solutions, today announced that it ... Company, and STI Technologies Limited to lower diabetes healthcare ... Through STI,s innoviCares card, which is available throughout all ... DarioHealth customers will be eligible for additional savings when ...
(Date:5/3/2017)... ROCKVILLE, Md. , May 3, 2017 /PRNewswire/ ... revenue growth of nine percent next year and ... solid organ and hematopoietic stem cell (HSCT) or ... and donor. Molecular testing technologies are well-suited for this ... healthcare-only market research publisher Kalorama Information. The various ...
Breaking Medicine Technology: